Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate

Trial Identifier: D9080C00001
Sponsor: AstraZeneca
Collaborator:
IQVIA
NCTID:: NCT04814680
Start Date: November 2021
Primary Completion Date: February 2022
Study Completion Date: February 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
KE Nairobi, KE, 00200
KE Nairobi, KE, 00100